• Home
• GJF
  • Joint Wound Care Formulary
  • . . . Introduction
  • 1. Gastro-Intestinal System
  • 2. Cardiovascular System
  • 3. Respiratory System
  • 4. Central Nervous System
  • 5. Infections
  • 6. Endocrine System
  • 7. Obstetrics, Gynaecology and Urinary Tract Disorders
  • 8. Malignant Disease and Immunosuppresion
  • 9. Nutrition and Blood
  • 10. Musculoskeletal and Joint Disease
  • 11. Eye
  • 12. Ear, Nose and Oropharynx
  • 13. Skin
  • 14. Immunological products and vaccines
  • 15. Anaesthesia
  • Appendix 1. Drugs for emergency use in General Practice
  • Appendix 2. Palliative Care
  • Appendix 3. Oral Nutritional Supplements (ONS)
  • Appendix 4. Gluten-free and cow's milk protein-free products
  • Medicines No Longer included in the GJF
  • Medicines not recommended for use in NHS Grampian
    • 1. Gastro-Intestinal System
    • 2. Cardiovascular System
    • 3. Respiratory System
    • 4. Central Nervous System
    • 5. Infections
    • 6. Endocrine System
    • 7. Obstetrics, Gynaecology and Urinary Tract Disorders
    • 8. Malignant Disease and Immunosuppresion
    • 9. Nutrition and Blood
    • 10. Musculoskeletal and Joint Disease
    • 11. Eye
    • 12. Ear, Nose and Oropharynx
    • Other Products
    • SMC Non Submission Statements
• eGJF
• Medicines Management
• Policies
• News Letters
• Shared Care Protocols
• Patient Group Directions

Medicines not recommended for use in NHS Grampian

Click here to view SMC "not recommended" statements for products where submissions have not been made. 

STOP PRESS
Rimonabant - non-formulary. Rimonabant (Acomplia®) was launched at the end of June.
SMC received a submission from Sanofi in October.  Advice should be available from SMC and then Formulary Group next year (Q1/2 2007).